A social-economic burden of rhinosinusitis with nasal polyps with comorbid asthma and influence of dupilumab
Rhinosinusitis with nasal polyps (RwNP) is a one of most common comorbidities in asthma and contrariwise and can lead to exacerbation of severe asthma (SA). Dupilumab is a perspective medicine for treatment of both, because it decreases exacerbations and prevents of a necessity of surgeon. Economics...
Saved in:
Main Authors: | I. S. Krysanov (Author), V. S. Krysanova (Author), V. Yu. Ermakova (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
by: I. S. Krysanov, et al.
Published: (2020) -
Th e clinical-economic analysis of Dupilumab in severe asthma
by: I. S. Krysanov, et al.
Published: (2021) -
Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
by: Kim J, et al.
Published: (2020) -
Social-economic burden of severe atopic dermatitis in the Russian Federation
by: I. S. Krysanov, et al.
Published: (2020) -
Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
by: Kariyawasam HH, et al.
Published: (2020)